Senior insider sale
SVP, Chief Medical Officer at AKEBIA THERAPEUTICS, INC. — senior position signals high conviction
$94.3K
67.66K shares
What this filing means
BURKE STEVEN KEITH plans to sell 67.66K shares of AKEBIA THERAPEUTICS, INC. valued at approximately $94.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001517022-26-000011
Officer· SVP, Chief Medical Officer
Since Aug 2019
67.66K
Shares to sell
$94.3K
Approx. market value
67.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
n/a
1/31/2026
67.66KTotal acquired67.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock n/a | 67.66K | — |
| Total | 67.66K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
67.66K
Market value
$94.3K
2/2/2026
Total
Units
67.66K
Value
$94.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 67.66K | $94.3K | Nasdaq | Planned |
| Total | 67.66K | $94.3K | ||